Population Diagnostics names new CTO
This article was originally published in Clinica
Executive Summary
Personalised medicine firm Population Diagnostics has appointed Peggy Eis chief technology officer. Dr Eis will have a "pivotal role" in the commercialisation of the company's DNA-based tests which identify rare, causative genetic biomarkers for diseases including autism, Parkinson's and Alzheimer's. The Melville, New York firm, which was founded in 2006, is also developing companion diagnostics to predict the efficacy and safety of targeted drugs. Dr Eis has 15 years of experience in genomics research, product and business development, and marketing. She most recently worked for Roche NimbleGen as senior director of genome variation, and was previously head of the comparative genomic hybridisation microarray group at NimbleGen Systems, which was acquired by Roche.